A Multi-Institutional Outcomes Analysis of Patients with Relapsed or Refractory DLBCL Treated with Ibrutinib.
Document Type
Journal Article
Publication Date
8-9-2017
Journal
Blood
DOI
10.1182/blood-2017-05-786988
APA Citation
Winter, A., Landsburg, D., Mato, A., Isaac, K., Hernandez-Ilizaliturri, F., Reddy, N., Smith, S., Shadman, M., Smith, M., Caimi, P., Jagadeesh, D., & Hill, B. (2017). A Multi-Institutional Outcomes Analysis of Patients with Relapsed or Refractory DLBCL Treated with Ibrutinib.. Blood, (). http://dx.doi.org/10.1182/blood-2017-05-786988
Peer Reviewed
1
